Loading

ImmunoShield Therapeutics

June 05, 2024
Start-Up Stadium Session
Platform for Therapeutics
5B
ImmunoShield Therapeutics seeks to enable the high-throughput biomanufacturing of hydrogel-based regenerative medicine products and the application of allogeneic cell products in the absence of chronic systemic immunosuppression, which will increase the safety of these products and broaden the eligible patient population.
Company Website: https://immunoshieldtherapeutics.com/

Company HQ City

Phoenix

Company HQ State

AZ

Company HQ Country

United States

CEO/Top Company Official

Oren Snir
Speakers
Matthew Becker
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS